Companies/US/RCUS

ARCUS BIOSCIENCES, INC.

Last · NYSE$22.53+0.02 (+0.09%)close · yahoo · 16h ago
Vol 1.21M ≈ 27.31M
Market cap$2.87B127.3M sh
P/E · TTM-5.8fwd -7.1 · eps -3.91 · loss
Beta0.94vs S&P 500
Div yield0.00%annual · TTM
52w range
$15.38$31.73
Volume1.2Msession

Issuer

Legal nameARCUS BIOSCIENCES, INC.
HQUnited States (US)
ListingUS RCUS
ISINUS03969F1093
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001724521
CIK0001724521
Employees601
AddressArcus Biosciences, Inc. 3928 Point Eden Way 94545, Hayward
Headline financial metrics
Revenue$40.0M
Operating income$-230.0M
Net income$-219.0M
Free cash flow$-257.0M
Operating margin-575.0%
Net margin-547.5%
Return on equity-47.2%
Period2026
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.87
Est. revenue
11.9M

Earnings transcripts

4 recent

Documents